Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


21.08.2017

1 Bioconjug Chem
1 Biomed Res Int
1 BJU Int
1 BMJ Open
2 Clin Cancer Res
1 Crit Rev Oncol Hematol
1 Environ Sci Pollut Res Int
1 Eur Urol
1 Indian J Clin Biochem
1 J Cell Biochem
1 J Int Med Res
1 J Magn Reson Imaging
1 J Membr Biol
1 J Occup Med Toxicol
1 Mol Biol Rep
2 Nat Rev Urol
2 Radiat Oncol
1 Surg Oncol
1 Surgery
1 Urol Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Bioconjug Chem

  1. LEE Y, Kischuk E, Crist S, Ratliff TL, et al
    Targeting and Internalization of Liposomes by Bladder Tumor Cells Using a Fibronectin Attachment Protein-Derived Peptide-Lipopolymer Conjugate.
    Bioconjug Chem. 2017;28:1481-1490.
    PubMed     Text format     Abstract available


    Biomed Res Int

  2. AVITAN O, Bahouth Z, Halachmi S, Shprits S, et al
    Histopathologic Differences between Jewish and Arab Population in Israel at First-Time Presentation with Bladder Cancer.
    Biomed Res Int. 2017;2017:8239601.
    PubMed     Text format     Abstract available


    BJU Int

  3. DUDDERIDGE T
    Positive messages for bladder cancer management in negative sentinel lymph node study.
    BJU Int. 2017;120:302-303.
    PubMed     Text format    


    BMJ Open

  4. OUGHTON JB, Poad H, Twiddy M, Collinson M, et al
    Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study.
    BMJ Open. 2017;7:e017913.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. ZENG S, Zhu Y, Ma AH, Yu W, et al
    The Phosphatidylinositol 3-kinase Pathway as a Potential Therapeutic Target in Bladder Cancer.
    Clin Cancer Res. 2017 Aug 14. pii: clincanres.0033.2017.
    PubMed     Text format     Abstract available

  6. KATES M, Date A, Yoshida T, Afzal U, et al
    Preclincial Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
    Clin Cancer Res. 2017 Aug 14. pii: clincanres.1082.2017.
    PubMed     Text format     Abstract available


    Crit Rev Oncol Hematol

  7. CORMIO A, Sanguedolce F, Musicco C, Pesce V, et al
    Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets.
    Crit Rev Oncol Hematol. 2017;117:67-72.
    PubMed     Text format     Abstract available


    Environ Sci Pollut Res Int

  8. FEKI-TOUNSI M, Khlifi R, Louati I, Fourati M, et al
    Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
    Environ Sci Pollut Res Int. 2017 Aug 12. doi: 10.1007/s11356-017-9767.
    PubMed     Text format     Abstract available


    Eur Urol

  9. LEOW JJ, Cole AP, Seisen T, Bellmunt J, et al
    Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA.
    Eur Urol. 2017 Aug 9. pii: S0302-2838(17)30640.
    PubMed     Text format     Abstract available


    Indian J Clin Biochem

  10. VERMA A, Kapoor R, Mittal RD
    Genetic Variation in CD166 Gene and Its Association with Bladder Cancer Risk in North Indian Population.
    Indian J Clin Biochem. 2017;32:292-300.
    PubMed     Text format     Abstract available


    J Cell Biochem

  11. WANG Y, Zhang H, Li X, Chen W, et al
    Differential expression profile analysis of lncRNA UCA1alpha regulated mRNAs in bladder cancer.
    J Cell Biochem. 2017 Aug 16. doi: 10.1002/jcb.26345.
    PubMed     Text format     Abstract available


    J Int Med Res

  12. GERULLIS H, Ecke TH, Barski D, Bantel C, et al
    Retrospective analysis of a surgical innovation using the IDEAL framework: radical cystectomy with epidural anaesthesia.
    J Int Med Res. 2017;45:714-722.
    PubMed     Text format     Abstract available


    J Magn Reson Imaging

  13. WANG F, Wu LM, Hua XL, Zhao ZZ, et al
    Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
    J Magn Reson Imaging. 2017 Aug 17. doi: 10.1002/jmri.25839.
    PubMed     Text format     Abstract available


    J Membr Biol

  14. GECIT I, Eryilmaz R, Kavak S, Meral I, et al
    The Prolidase Activity, Oxidative Stress, and Nitric Oxide Levels of Bladder Tissues with or Without Tumor in Patients with Bladder Cancer.
    J Membr Biol. 2017 Aug 16. doi: 10.1007/s00232-017-9971.
    PubMed     Text format     Abstract available


    J Occup Med Toxicol

  15. MASTRANGELO G, Carta A, Arici C, Pavanello S, et al
    An etiologic prediction model incorporating biomarkers to predict the bladder cancer risk associated with occupational exposure to aromatic amines: a pilot study.
    J Occup Med Toxicol. 2017;12:23.
    PubMed     Text format     Abstract available


    Mol Biol Rep

  16. HUSSEIN S, Mosaad H, Rashed HE, Ahmed S, et al
    Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
    Mol Biol Rep. 2017 Aug 14. doi: 10.1007/s11033-017-4118.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  17. THOMA C
    Bladder cancer: The promise of liquid biopsy ctDNA analysis.
    Nat Rev Urol. 2017 Aug 16. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  18. LOPEZ-BELTRAN A, Cheng L, Montorsi F, Scarpelli M, et al
    Concomitant bladder cancer and prostate cancer: challenges and controversies.
    Nat Rev Urol. 2017 Aug 16. doi: 10.1038/nrurol.2017.
    PubMed     Text format     Abstract available


    Radiat Oncol

  19. KRENGLI M, Pisani C, Deantonio L, Surico D, et al
    Intraoperative radiotherapy in gynaecological and genito-urinary malignancies: focus on endometrial, cervical, renal, bladder and prostate cancers.
    Radiat Oncol. 2017;12:18.
    PubMed     Text format     Abstract available

  20. NISHIOKA K, Shimizu S, Shinohara N, Ito YM, et al
    Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers.
    Radiat Oncol. 2017;12:44.
    PubMed     Text format     Abstract available


    Surg Oncol

  21. SHIGETA K, Kikuchi E, Hagiwara M, Ando T, et al
    Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma.
    Surg Oncol. 2017;26:73-79.
    PubMed     Text format     Abstract available


    Surgery

  22. ROIFE D, Kang Y, Wang L, Fang B, et al
    Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy.
    Surgery. 2017;161:1246-1254.
    PubMed     Text format     Abstract available


    Urol Oncol

  23. STEINBERG RL, Nepple KG, Velaer KN, Thomas LJ, et al
    Quadruple immunotherapy of Bacillus Calmette-Guerin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.
    Urol Oncol. 2017 Aug 8. pii: S1078-1439(17)30386.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: